Zoster Immunoglobulin-VF (CSL) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: varicella-zoster virus immunoglobulin
Pack: Zoster Immunoglobulin-VF (CSL) 200 units injection, 1 vial
Brand name
(ARTG)
: CSL ZOSTER IMMUNOGLOBULIN VF (human) 200IU injection vialDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
INDICATIONS AS AT 8 AUGUST 2002 : Zoster Immunoglobulin is indicated for prophylaxis against varicella in patients who meet all four of the criteria listed below: 1. One of the following underlying illnesses or conditions: a. Neoplastic disease (leukaemia or lymphoma); b. Congenital or acquired immunodeficiency; c. Immunosuppressive therapy with steroids or antimetabolites. 2. One of the following types of exposure to chickenpox or shingles patients: a. Household contact; b. Playmate contact (>1 hour play indoors); c. Hospital contact (in same 2 to 4 bedroom or adjacent beds in a large ward); d. Newborn contact (newborn of mother who had onset of chickenpox <5 days before delivery or within 48 hours after delivery); e. Premature infant (>= 28 weeks gestation) whose mother lacks a prior history of chickenpox; f. Premature infant (< 28 weeks gestation or <= 1000g) regardless of maternal history. 3. Negative or unknown history of chickenpox. 4. If Zoster Immunoglobulin can be administered within 96 hours after exposure. Zoster Immunoglobulin, Normal Immunoglobulin (immunoglobulin for intramuscular use) or plasma are of no value in the treatment of established varicella or zoster infection. High levels of circulating antibody do not prevent dissemination of infection. Zoster Immunoglobulin is not indicated for prophylactic use in immunodeficient children or adults when there is a history of varicella, unless the patient's immunosuppressed status is that which is associated with bone marrow transplantation.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intramuscular
- Clear to opalescent, colourless, solution
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 200IU x 1 pack
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems